Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial

Nicotine Tob Res. 2005 Aug;7(4):565-79. doi: 10.1080/14622200500185637.

Abstract

Medication noncompliance with smoking cessation pharmacotherapies is a significant problem in both research and clinical settings. This randomized, controlled, single-blind study compared three single-session psychological interventions to increase use of nicotine gum during a 15-day treatment period. A total of 97 adult smokers were randomized to receive standard treatment (ST, n = 31), brief feedback (BF, n = 32) plus ST, or contingency management (CM; i.e., payment for chewing at least 12 pieces/day on 10 of 15 intervention days, n = 34) plus ST and BF. Only the CM condition led to significantly greater average daily gum use (pieces/day: ST, 6.17; BF, 7.81; CM, 10.17 [p values <.05]) and higher rates of compliance (ST, 13.6%; BF, 25.2%; CM, 65.6% [p values <.001]). No differences were observed in smoking abstinence, nicotine withdrawal, or urinary cotinine as a function of treatment. Implications of the present findings are discussed, including application to clinical trials and extension to real-world use of nicotine gum.

Publication types

  • Controlled Clinical Trial
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Chewing Gum*
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nicotine / administration & dosage*
  • Nicotinic Agonists / administration & dosage
  • Psychotherapy, Brief / methods
  • Single-Blind Method
  • Smoking / drug therapy*
  • Smoking / psychology
  • Smoking Cessation* / methods
  • Time Factors
  • Tobacco Use Disorder / drug therapy*
  • Tobacco Use Disorder / psychology
  • Treatment Outcome

Substances

  • Chewing Gum
  • Nicotinic Agonists
  • Nicotine